Sana Biotechnology (NASDAQ:SANA) focuses on creating and delivering engineered cells as medicines for patients. They're deeply invested in developing therapies that touch on a wide range of medical areas, including oncology, diabetes, central nervous system disorders, and cardiovascular diseases. Their projects harness cutting-edge technology to modify the fundamental building blocks of life with the aim to treat, and potentially cure, debilitating medical conditions. With an innovative spirit at its core, Sana is dedicated to pushing the boundaries of medicine, striving to bring transformative and accessible treatments to people around the world. Their objectives are clear: innovate in the medical field, ensure treatments are patient-centric, and achieve lasting solutions to complex diseases.